Understanding protein-excipient interactions serves as a critical step in the rational design of formulations to stabilize and deliver protein- and peptide-based therapeutics. CD Formulation provides a range of advanced technologies and solutions to help customers understand protein-excipient interactions and optimize drug performance and stability. Our team has the experience and expertise to tailor solutions to our clients that best suit their needs.
Protein- and peptide-based drugs are increasingly popular in the pharmaceutical industry due to their specific targeting capabilities and low toxicity. However, these biologics are inherently unstable and may undergo degradation, aggregation, or denaturation during formulation and storage. Excipients are often added to protein and peptide formulations to improve their stability, solubility, and potency. Currently, a variety of excipients are used to stabilize proteins, inhibit protein aggregation, reduce surface adsorption, or simply provide physiological osmotic pressure. Stabilizers cover a wide range of molecules, including sugars, salts, polymers, surfactants, and amino acids. The effect of these excipients on protein stability in solution is mainly caused by their interaction with the protein and the container surface, most importantly with water. Some excipients stabilize proteins in solution by direct binding, while others use a number of fundamentally different mechanisms involving indirect interactions. Therefore, during formulation development, it is critical to study the multiple mechanisms by which excipients interact with proteins in solution and various interfaces and to explain how various interaction forces contribute to their observed stability effects on the protein.
Similar to small molecule drugs, in the development of protein and peptide formulations, the selection, optimization and characterization of excipients are very critical. This can be achieved through the properties, compatibility, solubility, stability, and protein-excipient interactions of the excipients. Research and testing are conducted to determine the best combination of excipients and to stabilize proteins and peptides and reduce aggregation.
At CD Formulation, we offer a wide range of protein/peptides-compatibility and interaction analysis services to support the timely development of your protein and peptide drug products. Our list of available services includes but is not limited to:
Technologies | Description |
Thermal Analysis Technology |
|
Spectroscopy Technology |
|
Chromatography Technology |
|
Microscopy Technology |
|
Published Data
Technology: Investigating protein-excipient interactions of a multivalent VHH therapeutic protein using NMR spectroscopy
Journal: MAbs
IF: 5.3
Published: 2022
Results:
The authors use nuclear magnetic resonance (NMR) spectroscopy to study the solution behavior of a multivalent VHH molecule composed of three flexibly linked heavy-chain-only domains that show dramatic stabilization against thermal degradation in the presence of sucrose. The result shows that NMR spectroscopy is a key tool to characterize and begin to understand the role of molecular flexibility in protein stabilization with potential applications in the design of novel therapeutic protein scaffolds.
The pictures of their study results are shown as follows.
Fig. 1. Effect of sucrose on MV-VHH protein behavior from NMR fingerprinting. (Panchal J, et al., 2022)
CD Formulation focuses on exploring the interaction between proteins and excipients to determine the most suitable excipients, optimizing drug stability and delivery performance. Please don't hesitate to contact us if you are looking for professional support and guidance to help you understand protein-excipient compatibility and interactions and optimize your formulation protocols. Let us work together to advance the development and application of protein- and peptide-based therapeutics.
References